FreeCME
LoginRegister Logout My Profile My Courses

Checkpoint Inhibitors in Oncology Practice: Optimizing Therapy, Preventing and Managing Immune-Related Adverse Events

CME 1.0

December 30, 2020
No Comments
KEYWORDS hematology / oncology
 / Print / Reprints /
| Share More
/ Text Size+
Larger Smaller
[X]

Related Articles

Recent Developments in Immuno-oncology: Biomarkers, Pan-tumor Studies, Novel Treatment Combinations, and the Management of Adverse Events

Recent Developments in Immuno-oncology: Biomarkers, Pan-tumor Studies, Novel Treatment Combinations, and the Management of Adverse Events

Related Events

Symposium 1 Enduring Archive: Assessing Clinical Implications of Biosimilars in Rheumatology Practice

Source: https://learning.freecme.com/a/36219P28bksr

Post a comment to this article